Fate Therapeutics Stock Price Target
Based on analysts offering 12 month price targets for fate in the last 3 months. Fate therapeutics stock price target raised to $88 from $40 at benchmark marketwatch.
The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00.
Fate therapeutics stock price target. Fate therapeutics stock forecast by wall street analysts. Today 200 day moving average is the resistance level ( 77.09 $). The analyst firm set a price target for 108.00 expecting fate to rise to within 12.
Fate therapeutics stock price target raised to $79 from $58 at stifel nicolaus marketwatch. Fate) was reported by hc wainwright & co. If response rates for its treatments fall, as is usually the case in cancer trials, this stock.
Code red — here’s what it means for the stock market now that company insiders are selling shares marketwatch. The consensus price target among wall street analysts represents a 101% premium over fate therapeutics' recent price. (fate) now what analysts predict::
The latest price target for. 125 rows jefferies financial group inc. This company's $6.7 billion market cap at the moment assumes a great deal of success down the road.
Stifel analyst benjamin burnett raised the price target on fate therapeutics (nasdaq: On average, they expect fate therapeutics' share price to reach $107.83 in the next twelve months. Tenthoff forecasts that the biopharmaceutical company will earn ($1.01) per share for the quarter.
Find the latest fate therapeutics, inc. List of events that could affect this stock. (fate) stock quote, history, news and other vital information to help you with your stock trading and investing.
According to the issued ratings of 16 analysts in the last year, the consensus rating for fate therapeutics stock is buy based on the current 4 hold ratings and 12 buy ratings for fate. Is set at 6.87, with the price to sales ratio for fate stock in the period of the last 12 months amounting to 256.38. (nasdaq:fate)’s beta value is currently sitting at 1.45, while the average true range indicator is currently displaying 3.23.
The trend in the analyst price target fate's average price target has moved up $30.95 over the prior 36 weeks. Get the stock price and latest news for fate and start trading today with zero commissions. 61 rows on nov 08, 2021 citigroup gave rating for fate.
Fate) to $118.00 (from $116.00) while maintaining a buy rating. Looking to buy fate therapeutics stock? The new note on the price target was released on february 26, 2021, representing the official price target for fate therapeutics inc.
The minimum target price for fate therapeutics analysts is $ 105.63. Also, this average forecast of $109.0 represents a 3.11% increase from the past average forecast of $105.71, 6 months ago from 7 wall street analysts. Fate updated stock price target summary.
The share price of fate therapeutics, inc. 8 wall street analysts that have issued a 1 year fate price target, the average fate price target is $106.63, with the highest fate stock price forecast at $130.00 and the lowest fate stock price forecast at $77.00. Fate therapeutics stock forecasts are adjusted once a day based on the closing price of the previous trading day.
Their forecasts range from $60.00 to $145.00. (nasdaq:fate) stock analysts at piper sandler issued their q1 2023 eps estimates for shares of fate therapeutics in a report issued on thursday, november 4th. Has the highest price target set, predicting fate will.
This suggests a possible upside of 92.7% from the stock's current price. Analyst ratings, historical stock prices, earnings estimates & actuals. The average true range (atr) for fate therapeutics inc.
Over the past 15 months,. Dow jones, a news corp company about wsj Earnings data q3 2021 12am gmt.
Post a Comment for "Fate Therapeutics Stock Price Target"